Cargando…

Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma

There is growing evidence that alternative splicing (AS) plays an important role in cancer development. However, a comprehensive analysis of AS signatures in kidney renal clear cell carcinoma (KIRC) is lacking and urgently needed. It remains unclear whether AS acts as diagnostic biomarkers in predic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Jukun, Liu, Yong Da, Su, Jiaming, Yuan, Dongbo, Sun, Fa, Zhu, Jianguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771988/ https://www.ncbi.nlm.nih.gov/pubmed/31140607 http://dx.doi.org/10.1002/jcp.28840

Ejemplares similares

Systematic analysis of survival‐associated alternative splicing signatures uncovers prognostic predictors for head and neck cancer
por: Liang, Ying, et al.
Publicado: (2019)

Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma
por: Meng, Tong, et al.
Publicado: (2019)

Alternative splicing associated with cancer stemness in kidney renal clear cell carcinoma
por: Xiao, Lixing, et al.
Publicado: (2021)

Identification of prognosis‐related alternative splicing events in kidney renal clear cell carcinoma
por: Zuo, Yongdi, et al.
Publicado: (2019)

Systematic profiling of alternative splicing signature reveals prognostic predictor for prostate cancer
por: Zhao, Jiyu, et al.
Publicado: (2020)

Systematic profiling of alternative splicing signature reveals prognostic predictor for cervical cancer
por: Hu, Yue-Xin, et al.
Publicado: (2019)

Patterns of Immune Infiltration in HNC and Their Clinical Implications: A Gene Expression-Based Study
por: Song, Jukun, et al.
Publicado: (2019)

Genome-wide Analysis of the Alternative Splicing Profiles Revealed Novel Prognostic Index for Kidney Renal Cell Clear Cell Carcinoma
por: Gao, Li, et al.
Publicado: (2020)

Is there a non-linear relationship between dietary protein intake and prostate-specific antigen: proof from the national health and nutrition examination survey (2003–2010)
por: Song, Jukun, et al.
Publicado: (2020)

Systematic Identification of Survival-Associated Alternative Splicing Events in Kidney Renal Clear Cell Carcinoma
por: Wei, Yubin, et al.
Publicado: (2021)

Prognostic Alternative Splicing Signatures in Esophageal Carcinoma
por: Dlamini, Zodwa, et al.
Publicado: (2021)

Genome-Wide Profiling of Alternative Splicing Signature Reveals Prognostic Predictor for Esophageal Carcinoma
por: Sun, Jian-Rong, et al.
Publicado: (2020)

Comprehensive Analysis of Prognostic Alternative Splicing Signature Reveals Recurrence Predictor for Papillary Thyroid Cancer
por: Liu, Mian, et al.
Publicado: (2021)

Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma
por: Zhang, Dong, et al.
Publicado: (2019)

Profiles of prognostic alternative splicing signature in hepatocellular carcinoma
por: Wu, Fangming, et al.
Publicado: (2020)

Identification of prognostic alternative splicing signature in gastric cancer
por: Wang, Zhiwu, et al.
Publicado: (2022)

Construction of the prognostic signature of alternative splicing revealed the prognostic predictor and immune microenvironment in head and neck squamous cell carcinoma
por: Ye, Fan, et al.
Publicado: (2022)

Classification of clear cell renal cell carcinoma based on PKM alternative splicing
por: Li, Xiangyu, et al.
Publicado: (2020)

Comprehensive analysis of prognostic alternative splicing signature in cervical cancer
por: Ouyang, Dong, et al.
Publicado: (2020)

Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer
por: Chen, Peigen, et al.
Publicado: (2020)

Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Immunological significance of alternative splicing prognostic signatures for bladder cancer
por: Li, Xinyun, et al.
Publicado: (2022)

Characterization of alternative splicing events and prognostic signatures in breast cancer
por: Han, Pihua, et al.
Publicado: (2021)

Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma
por: Chang, Ya-Sian, et al.
Publicado: (2020)

A Novel Prognostic Signature Associated With the Tumor Microenvironment in Kidney Renal Clear Cell Carcinoma
por: Pei, Dongchen, et al.
Publicado: (2022)

Identification and Validation of a Necroptosis-Related Prognostic Signature for Kidney Renal Clear Cell Carcinoma
por: Cai, Manbo, et al.
Publicado: (2023)

A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature
por: Chen, Wenwei, et al.
Publicado: (2022)

Prognostic alternative mRNA splicing signatures and associated splicing factors in acute myeloid leukemia
por: Jin, Peng, et al.
Publicado: (2020)

Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data
por: Ye, Ping, et al.
Publicado: (2021)

Identification of immune-based prostate cancer subtypes using mRNA expression
por: Song, Jukun, et al.
Publicado: (2021)

Genome-Wide Profiling of Prognostic Alternative Splicing Signature in Colorectal Cancer
por: Zong, Zhen, et al.
Publicado: (2018)

Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer
por: Xu, Lichao, et al.
Publicado: (2020)

Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma
por: Huang, Runzhi, et al.
Publicado: (2020)

Development and validation of an individual alternative splicing prognostic signature in gastric cancer
por: Lou, Shenghan, et al.
Publicado: (2021)

Correction to: Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Identification of prognostic and bone metastatic alternative splicing signatures in bladder cancer
por: Huang, Runzhi, et al.
Publicado: (2021)

Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer
por: Chen, Jiang, et al.
Publicado: (2022)

Identification of prognostic and bone metastasis‐related alternative splicing signatures in mesothelioma
por: Huang, Runzhi, et al.
Publicado: (2021)

Identification of Bone Metastatic and Prognostic Alternative Splicing Signatures in Prostate Adenocarcinoma
por: Zhu, Jiwen, et al.
Publicado: (2023)

Analyzing and Validating the Prognostic Value of a TNF-Related Signature in Kidney Renal Clear Cell Carcinoma
por: Zhang, Wenhao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9nfbfj3jsju5d9mlm7fen4o8l5